Multicenter Registration Study on Allergic Bronchopulmonary Aspergillosis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorPeking University Third Hospital
About this trial
To understand the current diagnosis and treatment status of ABPA patients, observe their clinical characteristics, prognosis, and treatment outcomes, and identify the relevant factors for poor prognosis in patients.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Peking University Third Hospital
Lead sponsor
First Affiliated Hospital of Guangxi Medical University
Collaborator
Guangzhou Institute of Respiratory Disease
Collaborator
Tongji Hospital
Collaborator
Nanfang Hospital, Southern Medical University
Collaborator
The First Affiliated Hospital with Nanjing Medical University
Collaborator
Qianfoshan Hospital
Collaborator
The First Affiliated Hospital of Shanxi Medical University
Collaborator
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Collaborator
West China Hospital
Collaborator
Second Affiliated Hospital of Xi'an Jiaotong University
Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborator
Xiangya Hospital of Central South University
Collaborator
Peking Union Medical College Hospital
Collaborator
Ruijin Hospital
Collaborator
Source ClinicalTrials.gov